Opening a New Front in the War Against Cancer: A Presentation by Dr. Craig Dees, Ph.D – March 31
Wednesday, March 31, 2010: 6 pm – 9 pm
Complimentary Cocktails: 6 pm – 7pm
Presentation: 7 pm
Location: Panevino Ristorante
246 Via Antonio
Las Vegas, NV 89119
(702) 222-2400
Members and Non-members welcome!
Join CFA Nevada for an insightful presentation on fighting cancer by Craig Dees, Chairman and CEO of Provectus Pharmaceuticals, followed by a lively Q&A session.
Provectus is a development stage company specializing in oncology and dermatology therapies that are safer, more effective, less invasive and more economical than conventional therapies. Provectus is conducting Phase 2 clinical trials of its proprietary drugs PV-10, as a therapy for metastatic melanoma, and PH-10, as a topical treatment for psoriasis and atopic dermatitis.
Craig Dees has spent more than 20 years in senior management positions at Photogen Technologies, the Oak Ridge National Laboratory, LipoGen, and TechAmerica. He was a founder, senior scientist and founding director of Photogen before Provectus was formed. Dees has been responsible for business and market applications, regulatory affairs, and commercialization of human and veterinary medical products. Craig’s awards include an R&D 100 for an industrial enzyme, an Inventor’s Forum New Product Award for a skincare product, and a First Saber Award for outstanding research in virology. He holds a Ph.D. in molecular virology from University of Wisconsin, Madison, a Master of Science degree in immunology from Auburn University, and a Bachelor’s degree in microbiology from Brigham Young University.
